NATIONAL AWARENESS AND EARLY DIAGNOSIS INITIATIVE (NAEDI)
NAEDI’s role is to co-ordinate and provide support to activities that promote the earlier diagnosis of cancer. NAEDI was announced in the Cancer Reform Strategy for England in 2007 and is being led by Mike Richards, National Cancer Director for England, and Harpal Kumar, Chief Executive of Cancer Research UK.
NAEDI consists of 4 work streams, one of which is Research, Evaluation and Monitoring. This work stream aims to generate high-quality, investigator-led research, ensures appropriate evaluation of NAEDI activities and works with the International Cancer Benchmarking Partnership. It is this work stream, under the auspices of NCRI, which oversees NAEDI’s research funding scheme.
NAEDI Research Calls
NAEDI’s second call closed in April 2011 and applications will go to committee in September 2011. NAEDI’s first call was issued in December 2009, and final funding decisions were made in October 2010.
NAEDI is sponsored by a consortium of funders brought together by NCRI. The current funders are:
- Cancer Research UK
- Department of Health (England)
- Economic and Social Research Council
- Health & Social Care Research & Development, Public Health Agency, Northern Ireland
- National Institute for Social Care and Health Research, Welsh Government
- Scottish Government
NAEDI Supplement in British Journal of Cancer
A special supplement to the British Journal of Cancer, Diagnosing Cancer Earlier: Evidence for a National Awareness and Early Diagnosis Initiative, was published in December 2009. The supplement brings together evidence underpinning NAEDI, and includes some of the novel work presented at the launch conference in November 2008, as well as a selection of other papers.
International Cancer Benchmarking Partnership
This programme is working to identify the root causes of survival differences between countries/jurisdictions with comparable health care systems and high quality cancer data. The programme aims to generate actionable insights which will help all partners improve cancer survival outcomes.
The first paper arising from the programme, ‘Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data’ was published in The Lancet in December 2010.
